financetom
Business
financetom
/
Business
/
MarketAxess Average Daily Volume Rises in November vs Year Ago
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MarketAxess Average Daily Volume Rises in November vs Year Ago
Dec 4, 2024 6:12 AM

08:37 AM EST, 12/04/2024 (MT Newswires) -- MarketAxess Holdings ( MKTX ) said Wednesday its total average daily volume came in at $44.95 billion in November, up 56% from a year earlier but down 3% compared to October.

Total rates ADV was $30.7 billion in November, up 112% from a year ago, but down 2% compared to October, the company said.

High-grade credit ADV was $6.53 billion in November, compared with $6.52 billion a year earlier, while high-yield credit ADV was $1.31 billion last month, compared to $1.91 billion a year ago, the company said.

MarketAxess ( MKTX ) shares fell more than 3% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Lionsgate Offering US Employees Voluntary Severance, Early Retirement Program, Deadline Reports
--Street Color: Lionsgate Offering US Employees Voluntary Severance, Early Retirement Program, Deadline Reports
Oct 2, 2024
02:40 PM EDT, 09/30/2024 (MT Newswires) -- Price: 7.14, Change: -0.15, Percent Change: -2.06 ...
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Oct 2, 2024
Sept 30 (Reuters) - Bristol Myers Squibb ( BMY ) won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning...
Wellchange Holdings Prices IPO
Wellchange Holdings Prices IPO
Oct 2, 2024
04:45 AM EDT, 10/02/2024 (MT Newswires) -- Wellchange Holdings said late Tuesday it priced its initial public offering of 2 million shares at $4 per share. Of the 2 million shares, 1.1 million are being offered by the company, while the remaining 900,000 are being offered by a selling shareholder. The company expects to raise gross proceeds of $4.4 million...
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Oct 2, 2024
(Reuters) - Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning contingent value rights (CVR) because...
Copyright 2023-2026 - www.financetom.com All Rights Reserved